
### [NCIT:C3808](http://purl.obolibrary.org/obo/NCIT_C3808)
**Label:** Rhabdoid Tumor

**Subclasses:** [NCIT:C68634](http://purl.obolibrary.org/obo/NCIT_C68634) (Childhood Atypical Teratoid/Rhabdoid Tumor), [NCIT:C8715](http://purl.obolibrary.org/obo/NCIT_C8715) (Rhabdoid Tumor of the Kidney), [NCIT:C133499](http://purl.obolibrary.org/obo/NCIT_C133499) (Recurrent Atypical Teratoid/Rhabdoid Tumor), [NCIT:C6586](http://purl.obolibrary.org/obo/NCIT_C6586) (Extrarenal Rhabdoid Tumor), [NCIT:C96847](http://purl.obolibrary.org/obo/NCIT_C96847) (Extrarenal Rhabdoid Tumor of the Liver), [NCIT:C6906](http://purl.obolibrary.org/obo/NCIT_C6906) (Atypical Teratoid/Rhabdoid Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C47816](http://purl.obolibrary.org/obo/NCIT_C47816) (Non-Neoplastic Osteoclast-Like Giant Cell) 57.14%
- Thing 52.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38828](http://purl.obolibrary.org/obo/NCIT_C38828) (Inositol Phosphate Metabolism Pathway))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 42.50%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 42.50%


